CD8A and neoplasm: Altogether, these findings show that IV BCG not only enhances the cytotoxic potential of lung NK and CD8+ T cells but also facilitates their recruitment into orthotopic LLC lung tumors, resulting in slower tumor growth and enhanced survival.